Crown Laboratories Acquires Bellus Medical, Completes Commercial Integration Plan

January 21, 2020

Crown Laboratories has announced that it has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown has been dedicated to transforming its Northeast Tennessee operations into a leading global skin care company. After acquiring its Beauty and Aesthetic divisions (formerly Vita Liberata and Bellus Medical, respectively) and strengthening its therapeutics portfolio through the acquisition of six consumer heritage brands from GlaxoSmithKline, Crown is now poised to become a global leader in dermatology health and wellness.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • SkinMedica launches Regenerative Science Advisory Board
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Advisory Committee to Review Seven Peptides for Potential Use in Compounding